BIOV:CC News and Press, Biovaxys Technology Corp. From 12/01/22

BioVaxys Announces Successful Test-Run Production of its Bi-Haptenized Ovarian Cancer Vaccine Canada NewsWire VANCOUVER, BC , Dec. 1, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is pleased to announ...

BIOVAXYS CLOSES FIRST TRANCHE OF NON-BROKERED PRIVATE PLACEMENT Canada NewsWire VANCOUVER, BC , Nov. 28, 2022 /CNW/ -- BioVaxys Technology Corp. ( CSE: BIOV, FRA: 5LB, OTCQB: BVAXF) ( "BioVaxys" or the "Company") announces that it has closed ...

BioVaxys Sarbecovirus Vaccine Interim Data Excellent Emerging Safety & Tolerability Profile with BVX-1021 BioVaxys Sarbecovirus Vaccine Interim Data Excellent Emerging Safety & Tolerability Profile with BVX-1021 Canada NewsWire VANCOUVER, BC , Nov...

BIOVAXYS ANNOUNCES COMPLETED PRIVATE PLACEMENT AND DEBT SETTLEMENT Canada NewsWire VANCOUVER, BC , Nov. 10, 2022 /CNW/ --  BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ( "BioVaxys" or the "Company") announces that it has completed...

VANCOUVER, BC / ACCESSWIRE / October 6, 2022 / The Power Play by The Market Herald has announced the release of new interviews with RDARS, Infinity Stone Ventures, BioVaxys Technology, and Sitka Gold discussing their latest news. The Power Play by The Market Herald provides investors with a...

BIOVAXYS ANNOUNCES DEBT SETTLEMENT Canada NewsWire VANCOUVER, BC , Oct. 6, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ( "BioVaxys" or the "Company") announces that it has agreed to settle an aggregate of $300,...

Palm Beach, FL – October 6, 2022 – FinancialNewsMedia.com News Commentary – The global Cervical Cancer Treatment market has been expanding for several years and is projected to continue at a growing CAGR. Cervical Cancer is a cancer arising from the cervix w...

BioVaxys Executes Binding Term Sheet for the US Marketing & Distribution for Papilocare Gel and Oral Immunocaps BioVaxys Executes Binding Term Sheet for the US Marketing & Distribution for Papilocare Gel and Oral Immunocaps Canada NewsWire Agreement Include...

VANCOUVER, BC / ACCESSWIRE / September 28, 2022 / The Power Play by The Market Herald has announced the release of a new interview with BioVaxys Technology discussing their latest news. The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know ab...

BioVaxys Further Expands Vaccines Intellectual Property Portfolio Canada NewsWire VANCOUVER, BC , Sept. 28, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced today that in an action that...